|
Cheaper Antibodies, Faster Medical Progress
(Thursday April 19 2007)
 | Continuing the infrastructural theme for today, ScienceDaily reports on better ways to produce antibodies for new therapies: "The group [developed] the new antibody-production approach to improve upon processes used previously to identify new drugs. Drug companies have used those more time- and labor-intensive processes to develop antibodies for treating rheumatoid arthritis, cancer and other diseases. The new approach [overcomes] those obstacles, and has other advantages. ... Our approach can provide a significant time savings. and it enables antibodies to be isolated to treat human diseases that may not be possible to obtain otherwise. ... Getting mammalian cells to produce lots of antibodies costs more, and can take several months. The direct bacterial approach [shaves] weeks off the production process." Real progress lies in making your tools and products work better and cost less in time and resources. That's what leads to more research, more widespread usage, and thus a greater rate of experimentation and improvement. |
|
